Polianta LTD Abb Vie Inc. Transaction History

Polianta LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 07, 2020	SELL	$85.91 - $100.83 $936,419 - $1.1 Million	-10,900 Closed	0 $0
Q2 2020 Jul 09, 2020	SELL	$73.37 - $98.18 $51,359 - $68,726	-700 Reduced 6.03%	10,900 $1.07 Million
Q1 2020 Apr 07, 2020	BUY	$64.5 - $97.79 $748,200 - $1.13 Million	11,600 New	11,600 $883,000
Q4 2019 Jan 13, 2020	SELL	$72.13 - $90.25 $1.14 Million - $1.43 Million	-15,800 Closed	0 $0
Q3 2019 Oct 09, 2019	BUY	$62.98 - $75.72 $995,084 - $1.2 Million	15,800 New	15,800 $1.2 Million

3,848

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.